Seeking Alpha

Coronado Biosciences slips on Oppenheimer downgrade

  • Coronado Biosciences (CNDO) falls 4.8% premarket.
  • Behind the move looks to be Oppenheimer, where analysts have cut the shares to Perform from Outperform.
  • $2.50 price target removed.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: